Elite Pharmaceuticals, Inc. (ELTP)
0.3881
0.00 (0.00%)
USD |
OTCM |
Mar 16, 15:57
Elite Pharmaceuticals Market Cap : 417.98M for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Glaukos Corp. | 5.750B |
| cbdMD, Inc. | 7.542M |
| ACADIA Pharmaceuticals, Inc. | 3.645B |
| Alnylam Pharmaceuticals, Inc. | 42.29B |
| Savara, Inc. | 1.065B |
Market Cap Related Metrics
| PE Ratio | 17.88 |
| PS Ratio | 3.060 |
| Price to Book Value | 5.204 |
| Price to Free Cash Flow | 24.87 |
| Price | 0.3881 |
| Earnings Yield | 5.59% |
| Operating PE Ratio | 8.296 |
| Normalized PE Ratio | 19.40 |